Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

The "Prostate Care Market (2025 Edition): Analysis By Treatment Type (Medications, Surgical Treatments, Minimally Invasive Therapies, and Radiation Therapy), By Disease Type, By End-User: Market ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

Multidisciplinary care in prostate cancer involves urologic, radiation, and medical oncologists, optimizing treatment through a collaborative approach. Clinical trials may benefit patients with ...

Recent advances in prostate cancer awareness have transformed how the disease is detected and treated. New screening tools, including AI-enhanced MRI and urine-based biomarker tests, are catching ...

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease. This review highlights how ...

Multidisciplinary teams, including various healthcare professionals, are essential for optimal prostate cancer care. Each patient's cancer journey is unique, influenced by disease stage, health, and ...

U.S. Senator John Boozman (R-AR) was recognized for his leadership in advancing policiies that prioritize enhanced care and research for prostate cancer.

BUFFALO GROVE, Ill., Feb. 4, 2026 /PRNewswire/ -- Tolmar, Inc. today announced the launch of Care Partner Corner (www.CarePartnerCorner.com), a comprehensive digital resource created specifically to ...

The MarketWatch News Department was not involved in the creation of this content. ALEXANDRIA, Va., Jan. 23, 2026 /PRNewswire/ -- ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action ...